Oscar Health (NYSE:OSCR) CAO Victoria Baltrus Sells 1,523 Shares

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 1,523 shares of Oscar Health stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $33,414.62. Following the transaction, the chief accounting officer owned 214,589 shares of the company’s stock, valued at approximately $4,708,082.66. The trade was a 0.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

OSCR traded up $3.04 during midday trading on Thursday, reaching $23.54. 10,696,223 shares of the company’s stock were exchanged, compared to its average volume of 7,845,401. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market capitalization of $7.10 billion, a PE ratio of -39.90, a P/E/G ratio of 1.48 and a beta of 2.37. The business’s 50-day moving average price is $17.92 and its 200 day moving average price is $15.93. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $25.58.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm’s quarterly revenue was up 52.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.92 earnings per share. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Institutional Trading of Oscar Health

A number of hedge funds have recently added to or reduced their stakes in OSCR. Thrive Capital Management LLC boosted its stake in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. acquired a new stake in Oscar Health in the 1st quarter worth about $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Oscar Health by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock worth $2,827,000 after buying an additional 8,879 shares during the last quarter. Jones Financial Companies Lllp boosted its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Oscar Health by 39.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after buying an additional 132,149 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently commented on OSCR shares. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday. Wolfe Research started coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating on the stock. Barclays increased their price objective on Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 26th. Robert W. Baird increased their price objective on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Finally, Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $20.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.